EMPLOYMENT AGREEMENT for PRESIDENT & CHIEF EXECUTIVE OFFICEREmployment Agreement • September 30th, 2021 • XEME Biopharma Holdings Inc. • Pharmaceutical preparations • New Jersey
AND: XEME Biopharma Inc. (the “Company”), an entity organized and existing under the laws of the State of Delaware, with its operations office located at: 7 Deerpark Drive, Suite M-1, Monmouth Junction, NJ 08852
ACQUSALUT INC. Miami Beach, FL 33141 May 26, 2020 XEME Biopharma, Inc. Manmouth Junction NJ 08852 Re: Letter of Intent (“LOI”) for a share exchange agreement between XEME Biopharma Inc. and Acqusalut Inc. Dear Gentlemen:Letter of Intent • June 2nd, 2020 • Acqusalut Inc. • Retail-retail stores, nec
This Letter of Intent will confirm our recent discussions and negotiations concerning Acqusalut Inc., a Florida corporation (“Acqusalut” the “Company”), XEME Biopharma Inc., a corporation incorporated in the State of Delaware (“XEME”) and the selling stockholders of XEME, R2T Biopharma Inc., a corporation incorporated in the State of California (R2T) which are made a party hereto (each, an “XEME Shareholder” and together with XEME and the Company, the “Parties” and each, a “Party”) for the purpose of executing a SHARE EXCHANGE AGREEMENT (the “Agreement”) after Acqusalut Inc., and XEME completed their audited financial statements for the year/s ending December 31, 2019 and March 31, 2020.
MFUSION CORP.Convertible Note Agreement • May 7th, 2019 • Acqusalut Inc.
This agreement is made on April 4, 2019 between Mfusion Corp (“the lender”) and Acqusalut Inc. (“the borrower”) for the lender to lend $10,000 to the borrower as a convertible note with Acqusalut Inc. giving the lender the option to convert this $10,000 to 100,000 Class A Common Stock of Acqusalut at $0.10 per share within six year from April 4, 2019.
SHARE EXCHANGE AGREEMENTShare Exchange Agreement • August 7th, 2020 • Acqusalut Inc. • Retail-retail stores, nec • Florida
This SHARE EXCHANGE AGREEMENT (this “Agreement”) is entered into by and between XEME Biopharma Holdings Inc. (previously Acqusalut Inc.) a Florida corporation (the “Company,” “the Registrant,” or “XBH”), XEME Biopharma Inc., a corporation incorporated in the State of Delaware (“XEME”) and the selling stockholders of XEME, R2T Biopharma Inc., a corporation incorporated in the State of California (“R2T”) which are made a party hereto (each, an “XEME Shareholder” and together with XEME and the Company, the “Parties” and each, a “Party”) to be effective concurrently with the time and date amended articles of incorporation (“AOC”) of XBH is filed to change its previous name to the new name and also change the stock structure of the company.
